User profiles for "author:Euzebiusz Jamrozik"
Euzebiusz JamrozikUniversity of Oxford Verified email at ethox.ox.ac.uk Cited by 1476 |
[HTML][HTML] The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
Vaccination policies have shifted dramatically during COVID-19 with the rapid emergence of
population-wide vaccine mandates, domestic vaccine passports and differential restrictions …
population-wide vaccine mandates, domestic vaccine passports and differential restrictions …
[HTML][HTML] COVID-19 human challenge studies: ethical issues
E Jamrozik, MJ Selgelid - The Lancet Infectious Diseases, 2020 - thelancet.com
COVID-19 poses an extraordinary threat to global public health and an effective vaccine
could provide a key means of overcoming this crisis. Human challenge studies involve the …
could provide a key means of overcoming this crisis. Human challenge studies involve the …
A systematic review of human challenge trials, designs, and safety
J Adams-Phipps, D Toomey, W Więcek… - Clinical Infectious …, 2023 - academic.oup.com
Background Few studies have assessed participant safety in human challenge trials (HCTs).
Key questions regarding HCTs include how risky such trials have been, how often adverse …
Key questions regarding HCTs include how risky such trials have been, how often adverse …
No jab, no job? Ethical issues in mandatory COVID-19 vaccination of healthcare personnel
R Gur-Arie, E Jamrozik, P Kingori - BMJ global health, 2021 - gh.bmj.com
HOW COMPLICATED CAN VACCINATING HCP AGAINST COVID-19 BE? On face value,
vaccinating HCP against COVID-19 first sounds simple: healthcare systems will receive …
vaccinating HCP against COVID-19 first sounds simple: healthcare systems will receive …
Ethics of controlled human infection to address COVID-19
Development of an effective vaccine is the clearest path to controlling the coronavirus
disease 2019 (COVID-19) pandemic. To accelerate vaccine development, some …
disease 2019 (COVID-19) pandemic. To accelerate vaccine development, some …
[HTML][HTML] COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities
In 2022, students at North American universities with third-dose COVID-19 vaccine
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …
[HTML][HTML] Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group
This report of the WHO Working Group for Guidance on Human Challenge Studies in COVID-
19 outlines ethical standards for COVID-19 challenge studies. It includes eight Key Criteria …
19 outlines ethical standards for COVID-19 challenge studies. It includes eight Key Criteria …
[BOOK][B] Ethics and drug resistance: collective responsibility for global public health
E Jamrozik, M Selgelid - 2020 - library.oapen.org
This Open Access volume provides in-depth analysis of the wide range of ethical issues
associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely …
associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely …
[BOOK][B] Human challenge studies in endemic settings: ethical and regulatory issues
E Jamrozik, MJ Selgelid - 2021 - library.oapen.org
This open access book provides an extensive review of ethical and regulatory issues related
to human infection challenge studies, with a particular focus on the expansion of this type of …
to human infection challenge studies, with a particular focus on the expansion of this type of …
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
YN Abo, E Jamrozik, JS McCarthy… - The Lancet Infectious …, 2023 - thelancet.com
The unprecedented speed of delivery of SARS-CoV-2 pandemic vaccines has redefined the
limits for all vaccine development. Beyond the aspirational 100-day timeline for tomorrow's …
limits for all vaccine development. Beyond the aspirational 100-day timeline for tomorrow's …